Latest News about MRK
Recent news which mentions MRK
From Benzinga
5 Biotech Stocks to Buy to Benefit From Biden’s New Cancer Cabinet
February 04, 2022
From InvestorPlace
From Motley Fool
COVID-19 treatments raked in billions of dollars in 2021. How will they do this year?
February 04, 2022
From MarketWatch
From InvestorPlace
Mid-Day Market Update: Nasdaq Down 2%; Biophytis Shares Spike Higher
February 03, 2022
From Benzinga
Mid-Morning Market Update: US Stocks Open Lower After Disappointing Earnings From Meta Platforms
February 03, 2022
From Benzinga
The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation
February 03, 2022
From Benzinga
Merck Coughs Up a Failure With Its "Pipeline in a Product"
February 03, 2022
From Motley Fool
Forecaster Yves Lamoureux has nailed several big market downturns. Here’s why he’s now turning bullish on stocks.
February 03, 2022
From MarketWatch
A Peek Into The Markets: Nasdaq Futures Tumble Following Downbeat Earnings From Meta
February 03, 2022
From Benzinga
3 Dividend Stocks That Can Make You Richer in February (and Beyond)
February 03, 2022
From Motley Fool
7 Stocks To Watch For February 3, 2022
February 03, 2022
From Benzinga
Earnings Scheduled For February 3, 2022
February 03, 2022
From Benzinga
Avoid Novavax for Now, Until the Picture Clears Up
February 02, 2022
From InvestorPlace
Amendments To Canada's Special Access Program (SAP) Allows Access To Restricted Psychedelic Drugs. How Will This Affect The Industry?
February 02, 2022
From Benzinga
What This FDA News Could Mean for Pfizer
February 01, 2022
From Motley Fool
2 Incredibly Cheap Value Stocks to Buy in February
February 01, 2022
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
January 31, 2022
From Benzinga
From Benzinga
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
January 31, 2022
From Benzinga
From Motley Fool
This ARK holding and pandemic star is down 77% from its peak — why one hedge fund is starting to buy it
January 31, 2022
From MarketWatch
3 Unstoppable Investments Everyone Needs in Their Portfolios
January 29, 2022
From Motley Fool
Abbott Labs Outlook Cools the Omicron Led Testing Boom
January 28, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.